May 7, 10:54 am
Growth stocks are companies that are scaling fast, growing revenue, expanding their teams, and attracting attention before the broader market catches on. We track these signals across thousands of companies using alternative data: job postings, web traffic, LinkedIn headcount, and social media growth. Here are six companies where the growth is happening right now.
For context, two stocks that showed similar patterns earlier this year, Applied Optoelectronics (AAOI) and ImmunityBio (IBRX), are now up 290% and 267% year-to-date. Both were hiring fast, generating surging web traffic, and growing their LinkedIn headcount months before the stock moved. These six are showing the same patterns today.
Revenue Growth: How Fast These Companies Are Scaling
Aerospace Products · $25.1B Market Cap · $274 · +70% 6-month return · AI Score 59
FTAI refurbishes and maintains jet engines, specifically the CFM56 and V2500, two of the most widely used engines in commercial aviation. Q1 2026 revenue hit $830.7 million, up 65% year-over-year and 12% above analyst estimates. The company doubled module production to 270 units in the quarter, and full-year 2026 revenue is now guided toward $3.3 billion.
The LinkedIn headcount tells the scaling story. FTAI went from 235 employees to 473 in under a year. Job postings spiked from single digits to over 50 open positions. The company is hiring to produce 1,050 modules in 2026 and is launching a joint venture targeting 100 aeroderivative power units for 2027.
AltIndex LinkedIn Employee Data
Jefferies recently raised its price target to $400. Eight analysts carry a "Strong Buy" consensus. The stock is up 70% in six months but still trades 23% to 58% below analyst targets.
The risk: FTAI trades at 49x earnings. EPS missed estimates by 16% in Q1 despite the revenue beat, so margins haven't caught up with the top line yet.
GPU Cloud Infrastructure · $72.9B Market Cap · $129 · +63% 6-month return · AI Score 69
Revenue went from $116 million in Q4 2023 to $1.57 billion in Q4 2025, roughly a 14x increase in two years. CoreWeave became one of the fastest cloud platforms ever to cross $5 billion in annual revenue. Management is guiding 2026 at $12 to $13 billion, backed by a $66.8 billion contracted revenue backlog. Multi-billion dollar deals with Meta, Anthropic, and Jane Street all signed in the past few months.
CoreWeave Quarterly Revenue (SEC Filings)
LinkedIn headcount grew 35% in six months to over 2,100 employees. Web traffic climbed 45% as enterprise buyers research GPU cloud options. CoreWeave reports Q1 2026 results today (May 7), with analysts expecting around $1.97 billion in revenue.
The risk: CoreWeave is still unprofitable, with an expected $0.91 per-share loss in Q1. Its $30 to $35 billion capex plan for 2026 is funded by aggressive debt. If AI infrastructure spending slows, the leverage works against them.
Biotechnology · $13.3B Market Cap · $67 · Flat 6-month return · AI Score 67
Job postings up 132%. Web traffic up 80%. LinkedIn headcount growing steadily. Revenue more than doubled. And the stock hasn't moved in six months.
The growth is coming from Atruby (acoramidis), BridgeBio's drug for ATTR cardiomyopathy, which generated $362.4 million in its first full year of sales. Q4 2025 alone produced $146 million, growing 35% quarter-over-quarter. Over 6,600 patients were prescribed Atruby by more than 1,600 prescribers. Total company revenue hit $502 million for FY2025, and analysts expect Q1 2026 revenue around $178 million.
AltIndex Job Postings Data
The hiring surge reflects BridgeBio expanding its commercial sales force as Atruby adoption grows. Two more drugs, encaleret and BBP-418, are expected to launch in late 2026 or early 2027, which would turn this into a multi-product platform. The AI Score of 67 is a buy signal.
The risk: BridgeBio posted a $182 million net loss in Q3 2025. The company is spending heavily on R&D and commercial buildout. Management projects cash-flow positive operations by 2028.
AAOI and IBRX showed these same signals earlier this year
Want to see what the data is showing next?
AltIndex tracks job postings, employee sentiment, insider trades, web traffic, and more for 10,000+ stocks. See the growth signals before the price moves.
Get Started for Free →
Space & Defense Technology · $1.7B Market Cap · $9.21 · +65% 6-month return · AI Score 58
Redwire's employee headcount surged 80% in six months, one of the fastest hiring rates of any publicly traded company. Job postings and web traffic are both growing alongside it.
Q1 2026 revenue came in at $97 million, up 58% year-over-year. The bigger story is the backlog: $498 million in contracted work, a record, up 71% year-over-year. The book-to-bill ratio hit 1.92, meaning Redwire is booking nearly twice as much new business as it delivers. Gross margins improved to 26.6%.
The contract wins are significant. Redwire landed a $1.8 billion IDIQ contract called Andromeda for advanced spacecraft, received its first order for the ELSA de-orbiting system, and secured follow-on Marine Corps orders for its Stalker drone. Management reaffirmed full-year 2026 revenue guidance of $450 to $500 million. The LinkedIn headcount surge isn't one program ramping. It's the entire portfolio scaling at once.
The risk: Q1 EPS missed badly at -$0.40 versus -$0.15 expected. The stock dropped 10.5% after earnings. Redwire is winning contracts but spending heavily to execute them. For believers in the backlog, the post-earnings pullback may be the opportunity.
LNG Infrastructure · $2.0B Market Cap · $7.51 · +27% 6-month return · AI Score 66
NextDecade is a different kind of growth story. There's no revenue yet. The company is building Rio Grande LNG, one of the largest LNG export facilities in the United States, with five trains under construction at the Port of Brownsville in Texas. First LNG is expected in the first half of 2027.
The alternative data is picking up the organizational buildout. Web traffic jumped 223% in six months as investor and counterparty interest grows. Job postings are up 52%. The company now has over 400 employees, mostly in Brownsville, building out commissioning and operations teams.
AltIndex Web Traffic Data
CEO Matt Schatzman said on the Q1 call that construction is ahead of schedule and within budget across all five trains. The economics look compelling: management estimates early LNG volumes could generate $1.2 to $2.0 billion in distributable cash flow, with early cargo sales already booked at margins above $3 per MMBtu. NextDecade has secured over $9 billion in financing and carries an AI Score of 66, a buy signal.
The risk: This is a binary outcome stock. $12.4 billion in total assets against a $2 billion market cap, with the balance sheet dominated by construction-in-progress. If Rio Grande delivers, the upside is substantial. If it doesn't, the equity gets diluted.
Data Monetization & AI · $448M Market Cap · $0.49 · -74% 6-month return · AI Score 56
Datavault AI is the wildcard. Web traffic surged from 5,000 to over 127,000 monthly visits. Job postings and LinkedIn headcount are both climbing. At the same time, the stock is down 74% in six months. The data and the price are telling completely different stories.
Q4 2025 revenue reached $33.8 million, up 3,650% year-over-year, and the company posted its first-ever profitable quarter. Full-year 2025 revenue was $39.1 million. Management is targeting $200 million for 2026.
AltIndex Web Traffic Data
The skepticism is understandable. The full-year net loss was $79 million. The balance sheet holds $92 million in crypto assets. Shares outstanding ballooned from 52 million to 573 million through convertible notes and warrants. At $0.49, the market is pricing in heavy doubt. Q1 2026 results are due May 15 and could be the deciding moment.
The risk: Sub-dollar stock with heavy dilution and an aggressive revenue target. The AI Score of 56 is a hold signal. This is a speculative position only.
The strongest stocks on this list are the ones where alternative data growth is backed by real revenue. FTAI with 65% revenue growth and a workforce that has doubled. CoreWeave with 235% topline expansion and a $66.8 billion backlog. BridgeBio with Atruby scaling fast while the stock sits flat. When companies are hiring, generating web traffic, and growing their social presence at the same time revenue is accelerating, the data is usually telling you something the price hasn't fully reflected yet.
Disclosure: This article is for informational purposes only and does not constitute investment advice. AltIndex aggregates publicly available alternative data signals. Past signal performance does not guarantee future results. Always do your own due diligence before making investment decisions.
Sign up and get access to a personalized dashboard, deeper insights, AI stock picks, stock alerts, weekly newsletter and much more.
